Furthermore, TBs are associated with resistance to conventional anti-cancer therapies, which may be explained by their low proliferative activity and resistance to apoptosis due to up-regulation of anti-apoptotic proteins including RAF-kinase inhibitor protein (RKIP) (Dawson et al., 2014). The gene discussed is PEBP1; the disease is cancer.